贪玩的万仇
Lv53
1320 积分
2024-04-07 加入
-
Antiangiogenic–immune-checkpoint inhibitor combinations: lessons from phase III clinical trials
9天前
已完结
-
Continuing, reducing, switching, or stopping antipsychotics in individuals with schizophrenia-spectrum disorders who are clinically stable: a systematic review and network meta-analysis
1个月前
已完结
-
Unlocking the potential of bispecific ADCs for targeted cancer therapy
1个月前
已完结
-
Abstract 12321: Discordant Association of Nonalcoholic Fatty Liver Disease With Lipoprotein(a) and Markers of Atherogenic Dyslipidemia
1个月前
已关闭
-
Cancer therapy with antibodies
1个月前
已完结
-
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
2个月前
已完结
-
SARS-CoV-2 recombinant spike ferritin nanoparticle vaccine adjuvanted with Army Liposome Formulation containing monophosphoryl lipid A and QS-21: a phase 1, randomised, double-blind, placebo-controlled, first-in-human clinical trial
2个月前
已关闭
-
The cell-line-derived subcutaneous tumor model in preclinical cancer research
2个月前
已完结
-
Bystander effect of antibody–drug conjugates: fact or fiction?
3个月前
已完结
-
Changing epidemiology of hepatocellular carcinoma in Asia
3个月前
已完结